Phase II study of regorafenib with dose adjustment and pharmacokinetic analysis in advanced colorectal cancer
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2638141
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Start with regorafenib 120mg/day, and escalate the dosage to 160mg/day if compatible with the criteria at day 15
Primary outcome(s): Desease control rate
Study Design: Single arm Non-randomized
创建时间：
2016-08-15
